论文部分内容阅读
肾癌转移的发生率很高,Mostofi分析1700例肾癌,有39%患者常在首次就诊时即发现转移,Skinnei报道在确诊肾癌时25～30%已有转移,deKernion报告作出肾癌诊断的同时已有转移者及在肾切除后发生转移者要占肾癌的50%左右。以往对于肾癌转移的治疗由于缺乏手段而常采取消极态度,但近年来,经过努力不懈的研究和探索,在治疗上有一定的进展,现介绍于下。肾癌转移的外科治疗一、肾脏切除术:肾癌转移是否常规作肾切除术目前仍有争论,deKernion报告作肾切除后,平均生存率只有4个月,10%患者生存一年。在肾切除后转移灶的消退只发生在0.8%病人中,而且这种消退
The incidence of kidney cancer metastasis is very high. Mostofi analyzed 1700 cases of kidney cancer. 39% of patients often found metastasis at the time of first visit. Skinnei reported that 25 to 30% of metastases have been diagnosed in kidney cancer. DeKernion reports kidney cancer diagnosis. At the same time, there are metastases and those who metastasize after nephrectomy will account for about 50% of kidney cancer. In the past, the treatment of kidney cancer metastasis often took a negative attitude due to lack of means. However, in recent years, after unremitting research and exploration, there has been some progress in treatment. Surgical treatment of kidney cancer metastasis First, nephrectomy: whether renal cancer metastasis routine nephrectomy is still controversial, deKernion reported after nephrectomy, the average survival rate was only 4 months, 10% of patients survived for one year. The resolution of metastases after nephrectomy occurred only in 0.8% of patients and this regression